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Abstract
This paper presents an ontology-driven treat-
ment article retrieval system developed and
experimented using the data and ground
truths provided by the TREC 2017 precision
medicine track. The key aspects of our sys-
tem include: meaningful integration of vari-
ous disease, gene, and drug name ontologies,
training of a novel perceptron model for article
relevance labeling, a ranking module that con-
siders additional factors such as journal im-
pact and article publication year, and compre-
hensive query matching rules. Experimental
results demonstrate that our proposed system
considerably outperforms the results of the
best participating system of the TREC 2017
precision medicine challenge.
1 Introduction
Providing useful precision medicine (PM)-related
information to clinicians treating cancer patients
is in high demand. For example, given a case with
patient’s disease (type of cancer), the relevant ge-
netic variants (genes, mutations, alterations), ba-
sic demographic information, and other potential
factors that may be relevant, the clinician may
want to find out biomedical articles addressing rel-
evant treatments for the given patient. The process
of manually searching relevant biomedical articles
requires lots of significant medical research and
investigation based on an underlying clinical sce-
nario, which is often time and effort consuming
due to the large volume of online medical articles
and the unstructured nature of the documents and
texts. To this end, we develop an automated med-
ical article retrieval system to enable clinicians ef-
ficiently find the most relevant medical research
articles useful for cancer treatments.
The Text REtrieval Conference (TREC) 2017
offered a PM track for this task, focusing on on-
cology and genetic mutations of cancer (Roberts
et al., 2017). TREC provides a January 2017 snap-
shot of about 27M PubMed Central (PMC) ab-
stracts and 30 synthetic patient profiles. The pa-
tient profiles consist of disease names, relevant
gene names and variations, patient demographic
information, and other conditions; one example
patient profile (a.k.a. topic) is shown below in Ta-
ble 1.
Disease: Lung adenocarcinoma
Genes: KRAS (G12C)
Demographic: 61-year-old female
Other: Hypertension, Hypercholesterolemia
Table 1: TREC topic example
In this paper, we conduct our experiments with
the TREC benchmark collection. The most no-
table aspects of our proposed article retrieval
system include: 1) leveraging various disease,
gene, and drug ontologies, 2) extensive query
formulation rules, 3) a novel perception model
for relevance labeling, and 4) a ranking module
that considers criteria such as publication recency
and journal impact factors. Experimental results
demonstrate that our system considerably outper-
forms the results of the best participating system
of the TREC 2017 precision medicine challenge.
2 System Description
We build an end-to-end pipeline for retrieving rel-
evant treatment-related biomedical articles given
a patient profile. The pipeline has four pre-
processing modules and nine main-cycle pro-
cesses, as shown in Figure 1.
2.1 Preprocess
The pre-processing modules are responsible for
clean the PubMed abstract data, the ontology data
and ranking resources, and then index these data
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Figure 1: The pipeline of our treatment-related biomedical article retrieval system.
in appropriate databases to make them readily for
use in the main retrieval process cycle.
PubMed abstracts. The TREC 2017 PM track
clearly stated the retrieval focuses on oncology
(Roberts et al., 2017), and the thirty patient pro-
files are all for human. Therefore, we would like
the pre-process to filter out non-cancer or non-
human treatment articles. To achieve this, we no-
tice each article in the PubMed abstract data set
comes with a MeSH code. The MeSH code system
(NIH, 2018) is a comprehensive controlled vocab-
ulary for the purpose of indexing journal articles
and books in the life sciences. We thus only keep
articles whose MeSH codes starting with either
"C" or "D", corresponding to the human "diseases"
and the "chemicals and drugs" category, and in-
dex them in an Elasticsearch database. The vast
majority the cancer-related and human-treatment-
related articles are under the two categories.
Ontologies. One distinct feature of our retrieval
system is the extensive inclusion of different on-
tologies. The TREC patient profile itself is insuf-
ficient to match with the database. The diseases
and genes might be represented by different terms
in different publications. Moreover, we believe the
existence of a related drug name is a significant in-
dicator of a relevant treatment article. These infor-
mation is not present in the TREC patient profile,
and our employment of the following ontologies
to expand user queries is crucial to the retrieval
performance.
• For diseases, we built a unified ontology
named MRCONSO (TODO: the meaning of
this name), merging UMLS (Bodenreider,
2004), ICD0 and ICD10 (Percy et al., 1990),
etc. In MRCONSO, different terms for the
same disease are mapped to a unique iden-
tifier so we know what terms are synonyms.
In addition, the 2018 MeSH data file (NIH,
2018) is also imported to our database; some
disease name aliases are available in this on-
tology.
• For genes, we imported the gene data from
NCBI and GeneMannia. (Warde-Farley
et al., 2010). Both ontologies contain syn-
onym and acronym information for human
genes. For example, with the help of both
ontologies, we are able to identify "Cyclin
Dependent Kinase 4", "Cell Division Protein
Kinase 4", "CDK4", "PSK-J3", "CMM3" are
all for the same gene.
• For gene variants, we uses the OncoKB
(Chakravarty et al., 2017). The latest ver-
sion has more than 4,000 unique mutations,
fusions, and alterations for nearly 600 cancer
associated genes. We’ll later show OncoKB
makes noticeable performance improvement
for the retrieval.
• For drug names, we applied the phrase2vec
model in (Hasan et al., 2015) trained with
the PubMed data to infer drug names from
RxNorm (Liu et al., 2005) that are related
to the provided diseases and genes. In ad-
dition, OncoKB also lists related drugs for
some variations.
Ranking resources. Currently the only
ranking resource used by our system is
the journal impact factors. We collected
the H5 indexes of life science related
journals from Google Scholar at https:
Figure 2: (a) a disease name matches with ontology MRCONSO and MeSH to find its synonyms/aliases; (b) a
gene name first matches with gene ontologies to find their synonyms/aliases, which further match with OncoKB
to find the gene variants.
//scholar.google.com/citations?
view_op=top_venues&hl=en. This data
enable our system to promote articles published
in better journals.
2.2 Retrieval
Our system now allows a clinician to input a
patient profile by entering disease names, gene
names, demographic information (e.g. gender,
age, race), and other conditions, etc. into the user
interface. For the evaluations in this paper, our
system directly reads the TREC patient profiles
from files. After that, our system goes through
several steps, starting with profile expansion, and
then query formulation and matching, and then it
does the relevance labeling relevance score ad-
justment and ranking, and finally it displays the
results to the user interface.
Profile expansion. The system searches for
synonyms or aliases of the disease names and
gene names in the indexed ontologies described
in section 2.1. All available gene variants are re-
trieved from OncoKB for the input genes. If a
gene variant is not specified in the patient pro-
file, then these variants will later be equally con-
sidered in the Elasticsearch query; otherwise, we
decide the retrieval should primarily consider the
specified variants. The system also identifies drug
names related to the input diseases and genes from
RxNorm. An illustration of profile expansion is
shown in 2.
Query formulation and matching. Our sys-
tem generally formulates elastic search queries
according to heuristic rules following the TREC
2017 relevance guidelines mentioned in section 1.
• The retrieved article must contain ALL of the
following,
– one disease name or one of its syn-
onyms/aliases.
– one gene name or one of its syn-
onyms/aliases.
– one gene variant if it is specified.
– one drug name related to the dis-
ease and gene, or one of some pre-
defined treatment keywords like "treat-
ment", "surgery", "therapy", "radiother-
apy", "immunotherapy", "chemother-
apy", etc.
• The returned article must not contradict with
the demographic requirement. For example,
if the patient profile specifies "male", then a
retrieved article must either be about male, or
not specifying a gender
• The retrieved article optionally matches the
following; if matched, a higher Elasticsearch
relevance score will be assigned to the re-
trieved article.
– gene variants, if none is specified.
– other conditions.
An Elasticsearch query is formulated by above
rules, and is then sent to the Elasticsearch indexing
system to match relevant articles. Each retrieved
article is assigned a relevance score by Elastic-
search, which is calculated a hybrid of several
relevance measurements tf-idf, Coord and Length
Norm (Gormley and Tong, 2015).
2.3 Relevance Labeling
Our system currently employs a Perceptron with
frequency features as its input. The frequency
features include bag-of-word and phrase frequen-
cies of disease names, gene names, drug/treatment
names in title, abstract and keywords respectively.
We experimented using three optimizers (SGD,
Adadelta, Adagrad) and 5 levels of learning rates
(1 to 10−5) are tested, and found Adadelta with
learning rate 0.01 has the best performance. We
use this perception for binary classification if each
label is relevant or irrelevant. Of course, some ir-
relevant articles might be incorrectly labelled; we
then depend on the relevance score and the rank-
ing to prevent irrelevant articles from entering the
top results. Our experiment in 3.2 shows this Per-
ceptron is beneficial to the retrieval performance.
2.4 Result Ranking
A real-life retrieval system should consider factors
other than relevance, even though it is not men-
tioned in TREC relevance guideline. For treatment
article retrieval, it is essential to consider publica-
tion recency and journal impact factors, as the on-
cology clinicians would highly expect recent treat-
ment methods published in good journals. The
principal of our article ranking is that the adjusted
relevance score is still the primary ranking factor,
but for articles with close relevance scores, other
factors come into play. By this idea, we define a
"closeness" parameter k, and let s be the adjusted
relevance score as discussed above, then the pri-
mary ranking score of our system is r1 = bs/kc
(b·c denotes a floor function). After this opera-
tion, some articles with close enough adjusted rel-
evance scores (within distance k) will have the
same primary ranking score. Currently our system
uses k = 20.
These extra factors are often of different scales.
For example, the journal impact factor can range
from 0 to hundreds, and the publication year
for our data set can range from 1950 to 2018.
Therefore, we first normalize all extra factors to
the range (0, 1) by a shifted function σ(x, x˜) =
1
1+e−c(x−x˜) where x denotes the factor to normal-
ize, x = x˜ is its symmetry axis, c is the horizon-
tal scale of the sigmoid curve, and x˜ can be inter-
preted as a threshold, and c decides how fast the
score increases when the factor x > x˜, and sym-
metrically how fast the score decreases when the
factor x < x˜. If the value of the factor x > x˜, then
it results in a score higher than 0.5. For example,
let y denote the publish year of a journal, and let
y˜ = 2008, c = 1, and σ(y, y˜) = 1
1+e−(y−2008) )
will give a score lower than 0.5 for articles before
2008, and a score higher than 0.5 for articles after
2008. After normalization, we calculate the sec-
ondary ranking score as
r2 =
ws(s mod k)
k + whσ(h, h˜)
+ wyσ(y, y˜)
where h denotes the journal impact factor, y de-
notes the article publication year; h˜, y˜ are the sym-
metric axes as defined above, and we use h˜ = 200,
y˜ = 2008; ws, wh, wy are weights for each corre-
sponding factor.
3 Experiments
3.1 Dataset
The original PubMed data set provided by TREC
has more than 27M abstracts. After the pre-
process as described in 2.1, a subset of 394,862
articles are indexed in the Elasticsearch. TREC
made a ground truth consisting of relevance labels
for 21,221 PubMed articles that are manually cu-
rated by oncologists. A label rates a PubMed arti-
cle as relevant by integer 2, or partially relevant by
integer 1 or irrelevant by integer 0. The relevance
is judged by the TREC 2017 relevance guideline.
Our subset of PubMed articles indexed in Elastic-
search includes all ground-truth articles.
3.2 Evaluation Results
The performance evaluation is conducted using
the standard trec_eval tool at https://trec.
nist.gov/trec_eval/. For a retrieval sys-
tem, the top results are most important; therefore,
we compare metrics like precision at 5/10 and
NCDG at 10. We also compare metrics includ-
ing R-precision and NDCG. The results are shown
in Table 2. The first column is the results when
all featurs of our system are on; in column 2,3,4,
some features are turned off to see how much im-
pact they have on the performance: 1) column 1
and column 2 show the ranking slightly improves
the performance; 2) column 1 and column 3 show
the OncoKB ontology brings noticeable enhance-
ment; 3) column 3 and column 4 show the effec-
tivenss of the perceptron relevance labeling.
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